Several types of epithelial neoplasms exhibit high expression of transforming growth factor b1 (TGF b -1), indicating that they have acquired tolerance to this normally growth inhibitory cytokine. Since cyclin D1 is expressed at high levels in murine skin tumors coincident with high levels of TGF b -1 expression, we hypothesized that cyclin D1 may override TGF b -1 induced growth arrest. We observed that in primary murine keratinocytes treated with TGF b -1, cyclin D1 is quickly suppressed at both the mRNA and protein level. Since changes in other cell cycle proteins occur at a later time during TGF b -1 treatment, the early suppression of cyclin D1 suggests that this gene is a critical target for TGF b -1 growth suppression. Using primary keratinocytes from transgenic mice that overexpress cyclin D1 (K5-D1 mice), we observed partial resistance to TGF b -1 growth inhibition. This resistance involves changes in the cyclin/ cdk/inhibitor complexes rather than dierences in expression of the TGF b receptors or signaling. Comparison of cdk associated kinase activity between wild-type and K5-D1 cells shows dierential regulation. We conclude that deregulated cyclin D1 and subsequent alterations in cell cycle machinery provides keratinocytes the ability to at least partially override growth inhibitory signals. Oncogene (2000) 19, 315 ± 322.
Introduction
The mammalian cell cycle is composed of four distinct sequential phases, such that completion of each is required for entry into the next phase. The acquisition of the malignant phenotype by a normal cell is characterized by its inability to undergo proper progression through these phases, hence resulting in the untimely and unrestricted replication of the cell. Recently, much work has focused on the role of the cell cycle machinery in the acquisition of this phenotype. The deregulated expression of particular members of the cyclin family has been shown to be associated with various types of malignancies (Sherr, 1995a) . In particular, the ampli®cation and deregulated expression of cyclin D1 has been described to occur in various human cancers (Sherr, 1995b) . Given that this gene is a sensor for extracellular signals, it has been proposed that deregulated expression confers autonomous cell growth. Furthermore, various laboratories have shown that suppression of cyclin D1 activity in a malignant cell can result in profound attenuation of the malignant phenotype (Sherr, 1995b) . Conversely, cyclin D1 overexpression in a normal cell results in the acquisition of characteristics normally associated with malignancy (Jiang et al., 1993; Quelle et al., 1993) . Therefore, there is very strong evidence that the ability of a cell to acquire this alteration would enhance its growth potential.
The antimitogenic eects of TGF b -1 on epithelial cells have been extensively studied (Ravitz and Wenner, 1997) . A link between TGF b -1 growth suppression and the cell cycle was provided by the observation that a hallmark feature of TGF b -1 inhibition was the decreased phosphorylation of pRb, which is functionally active in its hypophosphorylated state (Laiho et al., 1990) . Previous studies showed that expression of viral proteins capable of inactivating pRb provided resistance to TGF b -1 growth inhibition (Laiho et al., 1990; Pietenpol et al., 1990) . Also, ®broblasts derived from Rb nullizygous mice do not growth arrest in response to TGF b -1 (Herrera et al., 1996) . With the more recent discovery of new regulators of the cell cycle, it has become apparent that TGF b -1 induces a myriad of changes in the cell cycle regulating proteins that likely culminates in the decreased phosphorylation of pRb. TGF b -1 was shown to both suppress a variety of cell cycle genes, including cyclin D1 and cdk4, and to induce various cdk inhibitors such as p15, p21 and p27 (Ravitz and Wenner, 1997) . The induction of p15 results in the sequestration and inactivation of cdk4 and cdk6. Recent studies suggest that the association of p15 with cdk4 liberates p27 and allows it to interact with and suppress cyclin E/cdk2 activity, resulting in growth arrest (Reynisdottir et al., 1995) . This hypothesis is supported by the fact that deregulated expression of cdk4 has been shown to confer resistance to TGF b -1 (Ewen et al., 1993a) .
The overexpression of cdk4 likely perturbs the coordinated response of the dierent cdk inhibitors, resulting in incomplete suppression of the cdks. Furthermore, the deregulated expression of cyclin D1 in a Large T-antigen immortalized carcinoma cell line also results in resistance to TGF b -1 (Okamoto et al., 1994) . However, in this study it did not appear that cyclin D1 was aecting the dierent cyclin/cdk/ inhibitor complexes, but rather caused the downregulation of the expression of the type II TGF b -1 receptor. Finally, more recent reports have shown that both E2F-1 and c-myc can independently override TGF b -1 inhibition (Schwarz et al., 1995; Alexandrow et al., 1995) . Taken together, this suggests that alterations in cell cycle genes can alter the normal cellular response to TGF b -1 through very distinct mechanisms.
The keratinocyte cell cycle can be regulated by a variety of mitogenic and anti-mitogenic stimuli. TGF b -1 is a very potent inhibitor of keratinocyte growth in vitro. In vivo, it appears that TGF b -1 is important for the maintenance of keratinocytes in a non-proliferative state. Paradoxically, in mouse skin tumors induced by the two-stage carcinogenesis protocol overexpression of TGF b -1 mRNA has been shown to occur (Patamalai et al., 1994) . Furthermore, transgenic mice engineered to overexpress TGF b -1 in the epidermis have a very profound phenotype, including a higher rate of proliferative activity in both the basal and suprabasal epidermal layers (Fowlis et al., 1996) . This phenomenon is in apparent con¯ict with the proposed antimitogenic role of TGF b -1 on the regulation of keratinocyte growth.
This prompted us to examine the expression of TGF b -1, its receptors and the genes they regulate in keratinoctye cell lines derived from chemically induced mouse skin tumors. Consistent with the observed expression patterns in vivo, these cell lines overexpressed the mRNA for TGF b -1 and its receptors (SM Fischer, 1977, unpublished results) . Since these cell lines were not signi®cantly growth inhibited by TGF b -1, we hypothesized that alterations in the cell cycle machinery might underlie the observed resistance to TGF b -1 growth inhibition. We have previously reported that cyclin D1 is overexpressed very early during the development of chemically induced neoplastic lesions of the skin, probably as a result of H-ras activation (Bianchi et al., 1993; Robles and Conti, 1995) . Given the above mentioned eects of cyclin D1 overexpression on the growth of normal cells, we decided to examine the eect of TGF b -1 on primary keratinocytes isolated from transgenic mice which overexpress cyclin D1 in the basal layer of the epidermis (Robles et al., 1996) . This allowed us to examine the eect of a single alteration to the cell cycle machinery rather than the combined alterations that are frequently present in immortal cell lines. The epidermis of these mice has a higher proliferative activity than their wild-type littermates. In vitro these keratinocytes are partially resistant to TGF b -1 inhibition of growth, compared to wild-type cells, and have much reduced growth factor requirements. The overexpression of cyclin D1 in keratinocytes results in very profound alterations to the cell cycle which are likely due to changes in the cyclin/cdk/inhibitor complexes.
Results
To examine the eects of TGF b -1 on the protein steady-state levels of the dierent cell cycle regulatory proteins in primary mouse keratinocytes, we treated partially starved cells with fresh medium with or without TGF b -1. Keratinocytes maintained in the same medium for 48 h express relatively low levels of cyclin D1 and cyclin A, which is indicative of their low proliferative activity. Those keratinocytes treated with fresh medium only showed a signi®cant induction of cyclin D1 protein (Figure 1 ). In contrast, fresh medium plus TGF b -1 potently suppressed cyclin D1 expression, although we did observe some variability between dierent preparations of primary keratinocyte cultures. These results are consistent with those published by Ko et al., 1995. Of the other cell cycle proteins examined, only cyclin A was signi®cantly aected, but much later, approximately 12 h after treatment. The profound eect of TGF b -1 on cyclin D1 expression was intriguing given the previously observed upregulation of expression of cyclin D1 in keratinocyte tumor cell lines and skin tumors. We hypothesized that the overexpression of cyclin D1 in these cell lines and in tumors might provide the cell with a growth Figure 1 Eect of TGF b -1 treatment on expression of cell cycle proteins in primary keratinocytes. Primary mouse keratinocytes were treated with either: fresh medium (control) or fresh medium with 200 pmol TGF b -1 added (TGF-b) for the indicated times. Western blot analysis was carried out on whole cell lysates with polyclonal antibodies from Santa Cruz, as described in the Materials and methods section advantage, and quite possibly alter the response to TGF b -1.
We wanted to determine if the deregulated expression of cyclin D1 alone was capable of altering the response to TGF b -1. Since cell lines derived from mouse skin tumors may have multiple alterations that occurred during both tumorigenesis and in the establishment of cell lines, we chose to examine primary keratinocytes derived from transgenic animals that overexpress cyclin D1 in the basal layer of the epidermis, targeted through the use of the keratin 5 promoter (Robles et al., 1996) . To determine the regulation and activities of the cyclin D1 transgene in the keratinocytes, we immunoprecipitated cdk4 from asynchronous cultures of keratinocytes derived from the transgenic animals or their wild-type control littermates. In the control cells, we could detect all three D-type cyclins associating with cdk4 ( Figure 2A ). In contrast, cdk4 complexes from the transgenic keratinocytes had more cyclin D1 associated with it, and signi®cantly lower levels of cyclin D2/D3. Furthermore, both p27 and p21 were present in higher amounts in the cdk4 complexes from the transgenic animals. Examination of cdk4 and cdk6 complexes under dierent growth conditions revealed that cyclin D1 did not undergo any changes in response to growth factor deprivation in the transgenic cells ( Figure 2B ).
We then compared the eects of TGF b -1 on proliferation in wild-type and cyclin D1 overexpressing cells and found signi®cant dierences. As shown by others, TGF b -1 causes dramatic inhibition of proliferation within 24 h in wild-type keratinocytes (Ravitz et al., 1997) . K5-D1 keratinocytes, however, had a substantial resistance to TGF b -1 growth inhibition ( Figure 3) . A previous study (Okamoto et al., 1994) determined that the overexpression of cyclin D1 in a human esophogeal cancer cell line resulted in the downregulation of the TGF-b type II receptor. Therefore we sought to determine whether the observed resistance to TGF b -1 inhibition in K5-D1 cells was occurring through a similar mechanism. We immunoprecipitated the TGF-b type II receptor from two dierent sets of primary cultures and performed Western blot analysis to determine if there were any dierences in the level of receptor expression. Since we did not observe any dierences at the level of expression of the type II receptor ( Figure 4A ), we next veri®ed that the TGF b -1 signaling pathway of the cyclin D1 transgenic cells was intact. We performed Northern blot analysis for a known TGF b -1 responsive gene (Rundhaug et al., 1997) , matrix metalloprotease (MMP-9; gelatinase B) ( Figure 4B ). After 24 h of TGF b -1 treatment, MMP-9 expression was elevated in the wild-type and to a greater extent in the K5-D1 cells compared to untreated cells. Although the basis for the enhanced responsiveness of the K5-D1 cells is not known, these results indicated that the overexpression of cyclin D1 in the transgenic keratinocytes does not interfere directly with TGF b -1 signaling pathways.
We next investigated the possibility of alterations in the regulation of the cell cycle machinery. Analysis of cyclin D1 protein levels indicated that although in wild-type cells cyclin D1 was diminished by 24 h of TGF b -1 treatment, transgenic keratinocytes had no Figure 2 Comparison of cyclin/cdk complexes formed in wildtype (control) and K5-D1 transgenic primary keratinocytes. (A) Equal amounts of lysate from proliferating keratinocytes were subjected to immunoprecipitation with anti-cdk4 antibody and then Western blot analysis performed to determine protein interactions. Wild-type littermates (control) and transgenic (K5-D1); (B) Lysates from serum starved (C-Q for control and K5D1-Q for transgenic) and mitogenically stimulated for 24 h (C-M for control and K5D1-M for transgenic). Lysates were immunoprecipitated with anti-cdk 4 (K4) or anti-cdk 6 (K6) and subjected to Western blot analysis with the indicated antibodies. Note that p21 and p27 protein levels are higher in the K5-D1 immunocomplexes 3 H]thymidine was added during the last hour of incubation and label incorporation was determined; data were calculated as c.p.m./mg protein and expressed as a percentage of control (untreated). This data is representative of three independent experiments appreciable changes in cyclin D1 expression ( Figure 5) . Paradoxically, the level of p27 protein in the K5-D1 keratinocytes was signi®cantly higher than in their wild-type counterparts. Analysis of p27 immunocomplexes revealed very high levels of cyclin D1 associated with it in K5-D1 cells. Furthermore, cyclin D1 was associated at high levels with both cdk4 and cdk2. In both wild-type and transgenic cells, treatment with TGF b -1 induced a slight increase in association of p27 with both cdk2 and cdk4 by 8 h. The observation that there were higher levels of inhibitors present in K5-D1 keratinocytes prompted us to assess what eect this might have on the kinase activities of cdk2 after TGF b -1 treatment. Keratinocytes kept in the same medium for 2 days have a relatively low level of kinase activity when compared to restimulated cells ( Figure 6A ). Addition of fresh medium containing TGF b -1 resulted in both the suppression of phosphorylation of the Histone 1 substrate in in vitro kinase assays and the induction of the phosphorylation of cdk2-associated proteins migrating between 40 ± 66 kDa ( Figure 6A) . A comparison of the eects of TGF b -1 treatment on the phosphorylation of these cdk2-associated proteins reveals that there is a time dependent increase in the phosphorylation of these proteins in wild-type cells, whereas in K5-D1 cells these proteins do not become phosphorylated ( Figure 6B ). We do not know at present whether the altered cdk2 kinase activities in K5-D1 cells re¯ects the dierential association of proteins or changes in the substrate speci®city of cdk2.
The addition of fresh medium to keratinocytes induced a variety of changes in the expression of the cell cycle machinery components (Figure 1) . To determine the singular eect of cyclin D1 overexpression without the added eect of refeeding with fresh medium, we treated asynchronous cells that had been maintained in the same medium for 24 h prior to TGF b -1 treatment. This allowed us to assess the speci®c eect cyclin D1 overexpression has on growth and also on the expression of cell cycle regulatory genes. TGFb treatment resulted in a resistance to TGF b -1 growth inhibition that is similar to that in freshly fed cells (Figure 7) . Furthermore, it became clearly evident that many cell cycle genes were aected by cyclin D1 overexpression (Figure 8 ). In K5-D1 keratinocytes, cyclin D3 protein levels were considerably lower, whereas both cyclin E and cyclin A were slightly but consistently higher after TGF b -1 treatment. Both p107 and pRb protein levels were higher in K5-D1 cells. Since we have observed that expression of these two latter proteins is typically higher in actively cycling cells (i.e., not in G0), this suggests that the K5- Figure 5 Deregulated expression of cyclin D1 alters TGF b -1 induced changes in cyclin-cdk complexes. Primary keratinocytes from wild-type (control) and transgenic (K5-D1) were grown for 48 h in low-calcium medium after which fresh medium (with 200 pmol of TGF b -1) was added and lysates were recovered at the indicated times. Cyclin D1 and p27 steady-state protein levels were determined by Western blot. For analysis of protein interactions, immunoprecipitations were carried out on equal amounts of proteins with indicated antibodies (IP) and then subjected to Western blot analysis (WB). Note the higher levels of p27 protein in the K5-D1 lysates and the association of cyclin D1 and cdk2 D1 cultures have fewer quiescent cells. We also found that c-myc was expressed at higher levels in the K5-D1 keratinocytes (data not shown).
Finally, analysis of cdk2 and cyclin E kinase activities reveals that whereas in the wild-type cells where suppression of these activities is achieved within 8 h of TGF b -1 treatment, K5-D1 cells have both initially higher levels of kinase activities and the levels remain high for up to 8 h after treatment (Figure 9 ).
Discussion
We have provided de®nitive evidence that the overexpression of cyclin D1 can alter the response to TGF b -1 in primary mouse keratinocytes. Speci®cally, our results show that cyclin D1 overexpressing keratinocytes are at least partially resistant to TGF b -1 growth inhibition. This resistance correlates with a lack of complete suppression of cdk2 kinase activity. Although cyclin D1 overexpression had been previously shown to override TGF b -1 inhibition, the mechanism by which this was achieved was reported to involve the downregulation of the type II TGF b -1 receptor, rather than alterations in the cell cycle proteins (Okamoto et al., 1994) . One possible explanation for this dierence is that the previous study was based on a carcinoma cell line which had been immortalized with the SV40 Large T antigen. Since the expression of this viral protein in dierent cell types has been shown to alter cyclin/cdk complexes (Xiong et al., 1993) , this may explain the dierences between that study and ours. The ability of cyclin D1 to override TGF b -1 in the transgenic keratinocytes does not appear to be a result of alterations in the TGF-b type II receptor or its downstream signaling pathways, since we did not observe any dierences between control and transgenic Figure 8 Deregulated cyclin D1 alters expression of several cell cycle proteins. Primary wild-type (control) and transgenic (K5-D1) keratinocytes were given fresh medium 24 h before TGF b -1 treatment and then analysed by Western blot using polyclonal antibodies as indicated on the left of the ®gure cells at either level. Furthermore, this work diers from other published reports since we used primary rather than immortalized cells (Geng and Weinberg, 1993; Simon et al., 1995) . Previous studies in immortalized keratinocytes from both human and mouse have not described any changes in the level of cyclin D1. It is possible that during the immortalization process of those cells, changes in the regulation of cyclin D1 occur such that it is no longer regulated by TGF b -1.
An important feature of the cyclin D1 protein is the LXCXE motif, which was originally identi®ed in viral proteins that interacted with pRb (Ewen et al., 1993b) . Previous studies implicated the ability of these viral proteins to interact with pRb as a critical activity for altering the response to TGF b -1 (Ravitz et al., 1997). We could not consistently co-immunoprecipitate pRb with cyclin D1 from our K5-D1 keratinocytes, although this may be due to higher cyclin D1/cdk4 kinase activity levels (data not shown) which has been shown to destabilize the interaction between pRB and cyclin D1 (Ewen et al., 1993b; Hinds et al., 1992) . Consistent with this interpretation is the fact that we did ®nd that pRb was present in more highly phosphorylated forms in the transgenic keratinocytes (data not shown).
Overexpression of cyclin D1 in keratinocytes resulted in increased levels of many cell cycle regulating proteins. The aected genes were not only positive regulators of the cell cycle, but also negative ones. We consistently observed higher levels of cyclin E and cyclin A in the K5-D1 cells. The increased expression of c-myc, cyclin E and cyclin A are likely to play a role in the increased cdk2 activity that we observed in these cells. The deregulation of cdk2 activity is likely to be an important mechanism by which the transgenic keratinocytes are able to override the TGFb growth inhibitory signal. This is supported by the ®nding that overexpression of cyclin E results resistance to TGFb growth inhibition (Sgambato et al., 1997a) . Paradoxically, we also observed higher levels of p21, p27, p107 and pRb. Cyclin D1 transgenic keratinocytes express cdk2 at equivalent levels as their wild-type counterparts, but they have higher levels of both p21 and p27 associated with it. The fact that there is higher cdk2 kinase activity in the transgenic keratinocytes suggests that the inhibitory function of p21 and p27 may be compromised by the higher levels of cyclin E and cyclin A. Given the observed interactions between cyclin D1 and p27, we hypothesize that the cdk inhibitors may be held functionally inactive or at least attenuated in function. In the K5-D1 keratinocytes, cyclin D1/cdk4 complexes formed in the presence and absence of mitogenic signals. Furthermore, since we observed higher levels of both p21 and p27 associating with these complexes, it very likely that the inability to downregulate cyclin D1/cdk complexes results in the attenuation of the inhibitory function of both of these inhibitors. Consistent with this interpretation is the ®nding that the deregulated expression of cdk4 in mink lung epithelial cells can override TGF b -1 inhibitory signals and that cyclin D/ cdk 4 complexes can remove cdk inhibitors from cyclin E/cdk2 complexes resulting in the activation of the latter (Ewen et al., 1993a) .
Recent studies on human cancers have also identi®ed a correlation between the expression of p27 and cyclin D1 (Catzavelos et al., 1997; Fredersdorf et al., 1997; Porter et al., 1997; Ciparrone et al., 1998; Weinstein et al., 1997) . For instance, in tumors where p27 expression is very low, cyclin D1 is also low. Conversely, tumors that possess high levels of p27 also have abnormally high levels of cyclin D1. The observed increased expression of cyclin D1 and p27 in primary tumors (Sgamboto et al., 1997b; Ciparrone et al., 1998) has led to the suggestion that this constitutes a homeostatic feedback loop . This relationship between cyclin D1 and p27 prompted some investigators to propose that at some point during tumor development p27 becomes inactivated. One mechanism suggested was the downregulation of p27 expression, while the other was an increased expression of cyclin D1 resulting in the functional inactivation of this cdk inhibitor. Since it has been proposed that cyclin D1/cdk4 complexes serve to usurp free p27 and therefore not allowing p27 to bind to and inhibit cyclin E/cdk2 complexes, this latter interpretation appears reasonable (Sherr and Roberts, 1995c ). An implication of the human cancer study was that the increased expression of cyclin D1 was in response to the overexpression of p27. Although we cannot rule out this interpretation, studies in vitro have shown that in cells engineered to overexpress cyclin D1, p27 levels are elevated, suggesting that cyclin D1 can positively regulate the expression of p27 Han et al., 1996) . Furthermore, another study has shown that cyclin D1 can activate the p21 promoter (Hiyama et al., 1997) . In our study, we observed higher levels of both p21 and p27, although we do not know the mechanism involved in their upregulation. Further Figure 9 Cyclin E and cdk2 kinase activities are higher in K5-D1 keratinocytes and are partially resistant to TGF b -1 induced suppression. Cdk2 (A) and Cyclin E (B) were immunoprecipitated from lysates of wild-type (control) and transgenic (K5-D1) keratinocytes at the indicated times and subjected to in vitro kinase assays using Histone 1 as the substrate studies are needed to determine whether the increased expression of the cdk inhibitors is a compensatory mechanism generated by the cell to handle the deregulated levels of cyclin D1 protein. Other groups have found that the acute overexpression of cyclin D1 in a variety of cell lines is injurious (Jiang et al., 1993; Quelle et al., 1993; Hiyama et al., 1997) . Since expression of the cyclin D1 transgene occurs during the development of the animal, it is likely that the keratinocytes have adapted to chronically high levels of cyclin D1.
Our results have important implications on the development of tumors during the mouse skin two stage carcinogenesis protocol. An initial event in the development of these tumors is the activation of the Ha-ras gene. We have previously described that during the course of mouse skin tumor development, the cyclin D1 gene becomes ampli®ed and overexpressed and that this is an early event (Bianchi et al., 1993; Robles and Conti, 1995) . An apparent link between the activation of the Ha-ras gene and cyclin D1 has been demonstrated by a number of laboratories (Albanese et al., 1995; Filmus et al., 1994; Liu et al., 1995; Arber et al., 1996) . We and others have shown that expression of an activated Ha-ras results in higher levels of both cyclin D1 mRNA and protein.
In keratinocytes, the deregulated expression of Ha-ras results in substantially higher levels of cyclin D1 mRNA and protein, but more importantly, it unlinks the regulation of cyclin D1 expression from the dierentiation process (Martinez et al., 1999) . Taken together these ®ndings suggest a possible sequence of events (albeit simpli®ed) for the development of mouse skin tumors during the two-stage carcinogenesis protocol. Speci®cally, the initial activation of the Ha-ras gene results in the deregulated expression of cyclin D1. The inability of a cell to regulate the expression of cyclin D1 may then cause substantial alterations in the regulation of the cell cycle machinery that contributes to resistance to growth inhibitors and promotes the development of the tumor.
Materials and methods

Cell Culture
Primary mouse keratinocytes were cultured from epidermis of 1 ± 2 day old newborn SSIN mice. Brie¯y, the epidermis was incubated with 0.25% trypsin overnight at 48C. After removal of the dermis, keratinocytes were isolated and plated in high calcium (1.2 mM) EMEM with 10% fetal calf serum (Sigma) for approximately 3 h to allow the cells to attach. The cultures were then rinsed with warm PBS and refed with low calcium (0.05 mM) EMEM supplemented with 8% chelexed serum, EGF (5 ng/ml), insulin, phosphoethanolamine, transferrin, and hydrocortisone. Newborn mice from transgenic crosses were genotyped as described (Robles et al., 1996) . All experiments were performed on 3 day old cultures.
Keratinocyte cultures were treated with a range of doses (20, 200 and 600 pmol) of human recombinant TGF b -1 (R&D Systems) to determine the degree of growth inhibition. For all experiments involving analysis of cell cycle proteins, the amount of TGF b -1 used was 200 pmol. For some experiments, TGF b -1 was added concurrently with fresh medium. In other experiments TGF b -1 was added 24 h after the last medium change as described in the ®gure legend.
Analysis of DNA synthesis
[ 3 H]thymidine (5 uCi/ml) was added to the keratinocyte cultures 1 h before harvest. Following incubation with radioactive label, the cells were rinsed twice with ice-cold PBS and 10% TCA. After lysis in 0.2N NaOH, the cell lysates were analysed for label incorporation and protein concentration. Speci®c activities (c.p.m./mg protein) were calculated on triplicate or quadruplicate cultures.
Cell Cycle Protein Analysis
Protein was extracted from the cell cultures at dierent times after TGFb treatment. Cells were scraped on ice into ice-cold NP40 buer (50 mM Tris, 0.5% NP-40, 150 mM NaCl, 5 mM EDTA) containing protease inhibitors PMSF (1 mM), DTT (1 mM) and aprotinin (20 u/ml). Lysates were subjected to one cycle of freeze-thaw and subsequently clari®ed by cetrifugation. Protein concentration was determined using the Bio-Rad Dc protein assay kit. Approximately 20 ± 100 ug of protein were subjected to SDS ± PAGE (in 8 ± 12% gels), after which the protein was then transferred to nitrocellulose membranes. The blots were blocked with 5% milk in TBS. All antibodies used for Western blot analysis were from Santa Cruz. For Western blot analysis, all primary antibodies were used at a 1 : 1000 dilution and visualized with the ECL detection kit (Amersham).
For immunoprecipitations, cells were lysed in NP-40 buer as described above. Equal amounts of protein extracts were then reacted with antibody coupled to protein G agarose (GIBCO BRL) overnight and washed ®ve times in lysis buer. The samples were then boiled in loading buer and analysed as described above.
For kinase assays, following the last wash of the immunoprecipitations described above, antibody-bead complexes were resuspended in NP-40 buer containing 5 uCi g[ 32 P]ATP, 1 mg Histone H1 (Sigma) and 20 mm cold ATP per reaction. Kinase reactions were carried out at 308C for 30 min. The reactions were stopped by the addition of SDSloading buer and analysed by gel electrophoresis followed by autoradiography.
TGF b type II receptor expression and signaling
Primary keratinocytes from wild-type and transgenic mice were lysed in NP-40 buer as described above and the lysates used for immunoprecipitation with antibody against TGF b type II receptor (Santa Cruz) coupled to protein G agarose overnight. The samples were then washed, boiled in loading buer, subjected to SDS ± PAGE and blotted on nitrocellulose. Blots were probed with anti-TGF b type II receptor antibody and visualized with the ECL detection kit (Amersham).
To assess TGF b signaling, primary cultures of keratinocytes were treated with 200 pmol TGF b -1 for 24 h and the expression of MMP-9 assessed by Northern analysis, as we have previously described (Rundhaug et al., 1997) .
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